Cambridge Investment Research Advisors’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
Cambridge Investment Research Advisors's NEO Position: Q4 2021 in Review
Cambridge Investment Research Advisors sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 4,617 shares — an estimated $223K sold.
Cambridge Investment Research Advisors first reported a position in NEO in Q4 2015 and held it in 18 quarters. The position peaked at $551K in Q4 2020. 309 funds tracked by Wall St. Rank hold NEO as of Q4 2021.
- Cambridge Investment Research Advisors reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
- Cambridge Investment Research Advisors sold 4,617 NeoGenomics shares in Q4 2021, an estimated $223K.
- Cambridge Investment Research Advisors first reported a position in NeoGenomics in Q4 2015 and held it in 18 quarters.
- Cambridge Investment Research Advisors's NeoGenomics position peaked at $551K in Q4 2020.
- 309 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.
Based on Cambridge Investment Research Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.